Rob Leone
Rob Leone, Senior Director of Chemistry, Manufacturing and Controls (CMC) and Process Development (PD) at Acuitas Therapeutics, oversees the development of LNP manufacturing processes to support the clinical translation and commercialisation of nucleic acid therapeutics for partners. Rob earned his BSc in Microbiology and Immunology and an MSc in Biotechnology from the University of British Columbia. He has more than 25 years’ experience in pharmaceutical product development, specialising in novel drug delivery systems, establishing robust and scalable manufacturing processes, and technology transfer.
ArticleAdvancing gene editing: the role of lipid nanoparticles in CRISPR delivery
CRISPR therapies depend on delivery and lipid nanoparticles are emerging as a more flexible and scalable option than viral vectors.